For media inquiries, contact Paul Williams at [email protected] or +1 (310) 569-0023.
Press Releases
Scientific Presentations
February 22, 2022
Capillary Biomedical Receives
ISO 13485:2016 Quality System Certification
June 4, 2022
“Progressive Acceleration Of Insulin Exposure Over 7 Days Of Infusion Set Wear” presented at ADA’s 82nd Scientific Sessions
June 29, 2021
“Feasibility of an Investigational Extended Wear Infusion Set for Insulin Pump Therapy (IPT) in People with Type 1 Diabetes Mellitus.” presented at ADA’s 81st Scientific Sessions
January 19, 2022
Capillary Biomedical Receives FDA Approval to Begin Pivotal Trial of its SteadiFlow Seven-Day-Wear Infusion Set Technology
February 20, 2020
“Novel Kink-Resistant Insulin Infusion Set Causes Significantly Less Subcutaneous Tissue Inflammation Compared with a Straight Teflon Insulin Infusion Set” presented at the 13th International Conference on Advanced Technologies & Treatments for Diabetes
February 21, 2019
“Histological Comparison of Tissue Response to Investigational and Commercially-Available Continuous Subcutaneous Insulin Infusion (CSII) Sets in Live Swine” presented at the 12th International Conference on Advanced Technologies & Treatments for Diabetes
June 29, 2021
Capillary Biomedical Reports Best-in-Class Clinical Feasibility Results for its SteadiFlow Seven-Day-Wear Infusion Set Technology at ADA Scientific Sessions
June 22, 2018
“Micro-CT Imaging of an Insulin Bolus Infusion Through Continuous Subcutaneous Insulin Infusion (CSII) Sets in Live Swine: Quantitative Comparison of Distribution Patterns in Tissue Over Eight Days.” presented at ADA’s 78th Scientific Sessions
February 14, 2018
“Histological Comparison of Tissue Response for Stainless Steel and Teflon Continuous Subcutaneous Insulin Infusion (CSII) Catheters in Live Swine” presented at the 11th International Conference on Advanced Technologies & Treatments for Diabetes
October 7, 2020
Capillary Biomedical Receives
$1.5 Million from Helmsley Charitable Trust for Clinical Trials of New Insulin Infusion Technology
June 13, 2017
“Micro-CT Imaging of an Insulin Bolus Infusion Through Commercial Continuous Subcutaneous Insulin Infusion (CSII) Catheters in Live Swine: A Time Course Study of Distribution Patterns” presented at ADA’s 77th Scientific Sessions
July 6, 2016
“Tissue Histology Surrounding Continuous Subcutaneous Insulin Infusion (CSII) Catheters Implanted in Canines for 7 Days” presented at NIH’s Fourth Artificial Pancreas Workshop
August 14, 2018
Capillary Biomedical Closes
$2.9 Million Series Seed Financing for Commercialization of Novel Insulin Infusion Technology
October 22, 2015
“Optimization of Insulin Delivery through a CSII Catheter” presented at 15th Annual Diabetes Technology Meeting
June 13, 2017
Capillary Biomedical Sheds Light on the Mechanical Challenges of Insulin Pump Delivery Systems at Annual ADA Scientific Sessions
August 3, 2016
Capillary Biomedical Developing Improved Insulin Delivery Catheter with Funding Support from JDRF